Some MNCs in India have set up 100% subsidiaries. This has become the cause of concern for their Indian counterparts, as new product launches take place through these subsidiaries.
P&G Hygiene & Healthcare Ltd. (PGHH) is one such company which is facing a threat from its parent's 100% subsidiary P&G Home Products (PGHP). In the past few years, new product introductions from parentís product basket have been made through its 100% subsidiary. PGHP's present product portfolio consists of Ariel, Pantene, Head & Shoulder range of shampoos, Pringles, Camay and Gain Supersoaker detergent. On the other hand PGHH's product portfolio includes only two brands Whisper and Vicks. These two brands are facing stiff competition from the lower priced products and are suffering from the counterfeit products in the market.
Recently the parent has launched its world famous detergent brand Tide in India through its 100% subsidiary PGHP. It is P&G's largest brand with an annual turnover over $3 bn. The brand is targeted at the quality conscious consumers and offered at a comparative discounted price as compared to Leverís Surf and PGHP's Ariel. In the Rs 15 bn Indian detergent market Ariel enjoys the market share of 8%. Introduction of Tide might impact Ariel's sales growth.
Nevertheless, PGHH's bottomline continues to grow as a result of cost control initiatives taken by it and premium pricing of its products. However in the near future the company is likely to face tough competition not only from domestic companies but also from international players. As with the removal of quantitative restrictions easy imports of low priced products in different categories is likely to affect the revenue growth of Indian companies. To sustain in the scenario of intensifying competition, PGHH may have to launch new product in other categories to diversify the risk of being dependent on two brands.
Procter & Gamble Hygiene and Health Care has announced the first quarter results of the financial year ended June 2017 (1QFY17). The company's sales rose by 12.5%YoY while net profit rose by 50.1% YoY during the quarter.
LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA or Canada, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.
Equitymaster Agora Research Private Limited. 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India. Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: email@example.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407